Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M R Jacobs

Showing results (181-190 of 264) with videos related to

Pageof 27
Sort By:
European Journal of Clinical Microbiology|October 1, 1985
Evaluation of the Micro-ID, the API 20E and the Rapid 20E for same-day identification of EnterobacteriaceaeP C Appelbaum, M R Jacobs, M K Buick, et al.
Journal of Clinical Microbiology|February 12, 1998
Determination of penicillin MICs for Streptococcus pneumoniae by using a two- or three-disk diffusion procedureM R Jacobs, S Bajaksouzian, E L Palavecino-Fasola, et al.
Antimicrobial Agents and Chemotherapy|July 18, 2000
Mutations in 23S rRNA and ribosomal protein L4 account for resistance in pneumococcal strains selected in vitro by macrolide passageA Tait-Kamradt, T Davies, M Cronan, et al.
Current Eye Research|March 23, 2001
Release of complement regulatory proteins from ocular surface cells in infectionsE Cocuzzi, J Guidubaldi, D S Bardenstein, et al.
Diagnostic Microbiology and Infectious Disease|November 1, 2001
Cefditoren in vitro activity and spectrum: a review of international studies using reference methodsR N Jones, M A Pfaller, M R Jacobs, et al.
Antimicrobial Agents and Chemotherapy|April 1, 1997
Activities of beta-lactams against Acinetobacter genospecies as determined by agar dilution and E-test MIC methodsM A Visalli, M R Jacobs, T D Moore, et al.
The Journal of Antimicrobial Chemotherapy|March 1, 1996
Comparison of the activity of fluoroquinolones against Mycobacterium avium in cell-free systems and a human monocyte in-vitro infection modelH Shiratsuchi, M R Jacobs, A J Pearson, et al.
Antimicrobial Agents and Chemotherapy|August 3, 1999
Susceptibilities of Streptococcus pneumoniae and Haemophilus influenzae to 10 oral antimicrobial agents based on pharmacodynamic parameters: 1997 U.S. Surveillance studyM R Jacobs, S Bajaksouzian, A Zilles, et al.
Antimicrobial Agents and Chemotherapy|August 1, 1979
Antimicrobial susceptibility testing of pneumococci: determination of Kirby-Bauer breakpoints for penicillin G, erythromycin, clindamycin, tetracycline, chloramphenicol, and rifampinM R Jacobs, Y Mithal, R M Robins-Browne, et al.
Antimicrobial Agents and Chemotherapy|December 20, 2000
Susceptibilities of Haemophilus influenzae and Moraxella catarrhalis to ABT-773 compared to their susceptibilities to 11 other agentsK L Credito, G Lin, G A Pankuch, et al.
Pageof 27

Showing results (181-190 of 264) with videos related to

Sort By:
Pageof 27
European Journal of Clinical Microbiology|October 1, 1985
Evaluation of the Micro-ID, the API 20E and the Rapid 20E for same-day identification of EnterobacteriaceaeP C Appelbaum, M R Jacobs, M K Buick, et al.
Journal of Clinical Microbiology|February 12, 1998
Determination of penicillin MICs for Streptococcus pneumoniae by using a two- or three-disk diffusion procedureM R Jacobs, S Bajaksouzian, E L Palavecino-Fasola, et al.
Antimicrobial Agents and Chemotherapy|July 18, 2000
Mutations in 23S rRNA and ribosomal protein L4 account for resistance in pneumococcal strains selected in vitro by macrolide passageA Tait-Kamradt, T Davies, M Cronan, et al.
Current Eye Research|March 23, 2001
Release of complement regulatory proteins from ocular surface cells in infectionsE Cocuzzi, J Guidubaldi, D S Bardenstein, et al.
Diagnostic Microbiology and Infectious Disease|November 1, 2001
Cefditoren in vitro activity and spectrum: a review of international studies using reference methodsR N Jones, M A Pfaller, M R Jacobs, et al.
Antimicrobial Agents and Chemotherapy|April 1, 1997
Activities of beta-lactams against Acinetobacter genospecies as determined by agar dilution and E-test MIC methodsM A Visalli, M R Jacobs, T D Moore, et al.
The Journal of Antimicrobial Chemotherapy|March 1, 1996
Comparison of the activity of fluoroquinolones against Mycobacterium avium in cell-free systems and a human monocyte in-vitro infection modelH Shiratsuchi, M R Jacobs, A J Pearson, et al.
Antimicrobial Agents and Chemotherapy|August 3, 1999
Susceptibilities of Streptococcus pneumoniae and Haemophilus influenzae to 10 oral antimicrobial agents based on pharmacodynamic parameters: 1997 U.S. Surveillance studyM R Jacobs, S Bajaksouzian, A Zilles, et al.
Antimicrobial Agents and Chemotherapy|August 1, 1979
Antimicrobial susceptibility testing of pneumococci: determination of Kirby-Bauer breakpoints for penicillin G, erythromycin, clindamycin, tetracycline, chloramphenicol, and rifampinM R Jacobs, Y Mithal, R M Robins-Browne, et al.
Antimicrobial Agents and Chemotherapy|December 20, 2000
Susceptibilities of Haemophilus influenzae and Moraxella catarrhalis to ABT-773 compared to their susceptibilities to 11 other agentsK L Credito, G Lin, G A Pankuch, et al.
Pageof 27